IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Pivotal bioVenture Partners Investment Advisor LLC

Q2 2024 Holdings

Filed 2024-08-13 | 10 holdings | $130.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Vaxcyte Inc(PCVX)COM92243G108$59.9M793,03646.0%
Inozyme Pharma IncCOM45790W108$20.0M4,494,85115.4%
Oculis Holding AG(OCS)ORDINARY SHARESH5870P102$19.1M1,595,91814.7%
Arcutis Biotherapeutics Inc(ARQT)COM03969K108$19.0M2,041,10814.6%
Exscientia PLCADS30223G102$3.9M770,5003.0%
Rallybio CorpCOM75120L100$3.2M2,404,6442.5%
Vigil Neuroscience Inc(VIGL)COM92673K108$2.2M560,5951.7%
Bolt Biotherapeutics Inc(BOLT1EUR)COM097702104$1.4M1,891,4671.1%
IO Biotech Inc(IOBT)COM449778109$1.0M864,1970.8%
Aligos Therapeutics IncCOM01626L105$260.1K743,2150.2%